REVOLAX Sub-Q With Lidocaine (1 x 1.1ml)

REVOLAX Sub-Q: The Thickest Filler of the Leading REVOLAX Dermal Filler Range

Part of the Fox Pharma exclusive REVOLAX range, REVOLAX Sub-Q is an exceptionally high-quality dermal filler designed for areas with more extreme lines and wrinkles. As the most viscous filler in the REVOLAX range, Sub-Q is formulated with the highest quality hyaluronic acid to both volumise and contour areas that require more structural support.

Fox Pharma are dedicated to providing authentic and safe products. The new box with the holographic logo ensures an easily identifiable, traceable product that is sourced and distributed only through official UK & NI license holders, Fox Pharma.

REVOLAX Sub-Q Key Features

• Thickest dermal filler of the leading REVOLAX range
• Results last around 12-18 months post-treatment
• Biodegradable & non-animal based
• Cross-linked dermal filler for deep subcutaneous implantation
• Class III CE-marked, meaning it adheres to strict safety, health and environmental standards

REVOLAX Sub-Q Treatment Areas

• Deep to severe lines
• Nasolabial folds
• Cheek
• Chin
• Nose
• Jawline augmentation

Composition

• Hyaluronic acid concentration 24mg/ml
• Lidocaine HCl 0.3%
• Volume 1.1ml
• Duration 12-18 Months
• 280 Pa

REVOLAX Sub-Q Benefits

REVOLAX Sub-Q’s incredible popularity comes from the many incredible benefits that it provides. These benefits include, but are not limited to;

• Long-lasting results
• Effective treatment of deep wrinkles
• Formulated with high-quality hyaluronic acid
• Impressive sculpting and contouring results
• Results are visible after just one treatment

REVOLAX Sub-Q Contraindications

• Women who are pregnant or breastfeeding
• People under the age of 18
• Patients who are known to demonstrate hypersensitivity to hyaluronic acid.
• Patients who are known to demonstrate hypersensitivity to lidocaine.
• Patients who tend to develop hypertrophic scarring.
• Immediately before or post laser therapy, chemical peeling or dermabrasion.
• Areas presenting cutaneous inflammation or signs of infection.